The Veteran's tinea versicolor was rated at 10 percent prior to October 18, 2016 and 30 percent thereafter. The Board found that the evidence did not support higher ratings for any time period on appeal.
The deciding factor: The VA examinations and findings demonstrated that the disability affected less than 40% of the Veteran's total body area prior to October 18, 2016, and at least 20-40% thereafter. There was no evidence or finding of systemic therapy such as corticosteroids or immunosuppressive drugs required for a higher rating.
- Claimed conditions
- tinea versicolor
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 10%
- Decision date
- January 9, 2018
- Citation
- 1801371
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1801371.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board is remanding the claim for tinea versicolor to ensure that VA fulfills its duty to assist by obtaining private medical records and potentially scheduling a new examination.
- Granted
The Board granted service connection for enlarged liver (fatty infiltration), benign prostate hypertrophy, and tinea versicolor as secondary to the Veteran's service-connected diabetes mellitus, type II.
- Partly granted
The Board granted readjudication for the claims of service connection for left foot hallux valgus and tinea versicolor, but denied the claims for tinea corporis, tinea cruris, carbuncle, cyst, and scarring secondary to tinea versicolor.
- Partly granted
The Board granted a 10 percent disability rating for dermatitis, variously diagnosed as seborrheic dermatitis, dermatophytosis, and tinea versicolor, prior to June 5, 2023, but denied a higher rating from that date. The issues related to Raynaud's syndrome and special monthly compensation were remanded.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.